BRIEF published on 11/21/2024 at 07:05, 5 hours 31 minutes ago Xlife Sciences AG annonce la prochaine cotation de FUSE-AI GmbH Innovation Médicale Xlife Sciences AG Bourse De Londres FUSE-AI GmbH Technologie De L'IA
BRIEF published on 11/21/2024 at 07:05, 5 hours 31 minutes ago Xlife Sciences AG Announces Upcoming Listing of FUSE-AI GmbH London Stock Exchange AI Technology Xlife Sciences AG Medical Innovation FUSE-AI GmbH
PRESS RELEASE published on 11/21/2024 at 07:00, 5 hours 36 minutes ago Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 Xlife Sciences AG announces planned IPO of FUSE-AI GmbH on London Stock Exchange in first half of 2025, expanding into AI healthcare sector London Stock Exchange IPO Xlife Sciences AG AI Healthcare FUSE-AI GmbH
BRIEF published on 09/30/2024 at 20:05, 1 month 20 days ago Xlife Sciences AG envisage une double cotation à la Bourse de Londres Investisseurs Internationaux Capitalisation Boursière Bourse De Londres Liquidité Des Stocks Double Cotation
BRIEF published on 09/30/2024 at 20:05, 1 month 20 days ago Xlife Sciences AG Plans Dual Listing on London Stock Exchange London Stock Exchange Dual Listing Market Capitalization International Investors Stock Liquidity
PRESS RELEASE published on 09/30/2024 at 20:00, 1 month 20 days ago Xlife Sciences AG enables international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG) Xlife Sciences AG plans dual listing on London Stock Exchange Group to increase market capitalization and liquidity, benefiting shareholders Shareholders Dual Listing Market Capitalization Xlife Sciences AG London Stock Exchange Group
BRIEF published on 09/19/2024 at 07:05, 2 months 2 days ago Xlife Sciences AG : Premier semestre 2024 réussi avec des progrès stratégiques et des chiffres financiers solides Partenariats Stratégiques Performance Financière Sciences De La Vie Rapport Semestriel 2024 Sciences De La Vie X
BRIEF published on 09/19/2024 at 07:05, 2 months 2 days ago Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Strategic Partnerships Financial Performance Life Sciences Xlife Sciences 2024 Half-Year Report
PRESS RELEASE published on 09/19/2024 at 07:00, 2 months 2 days ago Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Xlife Sciences AG reports successful first half of 2024 with strategic progress and solid financial figures, including revenue growth and international partnerships Strategic Partnerships Revenue Growth Financial Report Business Development Xlife Sciences AG
BRIEF published on 09/03/2024 at 07:05, 2 months 18 days ago Xlife Sciences AG Completes Strategic Review Process by Q3 2024 Shareholders Portfolio Value Creation Strategic Review Implementation
Published on 11/21/2024 at 12:00, 36 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 36 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 6 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 33 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 36 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:15, 21 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 6 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 35 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 29 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 16 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
